Verve Therapeutics Inc (VERV) Ownership

13.25 ↓0.03 (-0.23%)
As of March 28, 2024, 3:59pm EST.

Institutional Ownership

Alphabet Inc is the biggest individual institutional holder of Verve Therapeutics Inc (VERV), owning a total of 12.3 million shares. Combined, the top 32 institutional holders of VERV own 89.30% of the company with a total of 72.5 million shares.

In the latest ownership report on December 31st 2023, the top 32 institutional holders increased their combined ownership of VERV by 9.5 million shares. 16 institutions bought 13,282,135 total additional shares and increased their ownership by an average of 38.44%. However 3 institutions sold 3,800,266 total shares and decreased their ownership by an average of 30.37%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Verve Therapeutics increased by a net total of 9,481,869 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Alphabet Inc14.768%17.063%12,349,0861,800,0002023-12-31
ARK Investment Management LLC8.401%35.084%7,025,1161,824,5492023-12-31
Vanguard Group Inc6.544%13.221%5,471,930638,9622023-12-31
BlackRock Inc5.304%10.931%4,435,481437,0822023-12-31
Federated Hermes Inc4.760%57.180%3,980,3721,448,0032023-12-31
State Street Corporation4.624%17.991%3,866,764589,5842023-12-31
FMR Inc4.119%-47.632%3,444,570-3,132,9922023-12-31
T. Rowe Price Investment Management,Inc.3.796%50.779%3,174,3521,069,0542023-12-31
Casdin Capital, LLC3.599%1.841%3,009,09454,3842023-12-31
Nikko Asset Management Americas Inc2.867%11.660%2,397,604250,3612023-12-31
Sumitomo Mitsui Trust Holdings Inc2.867%11.660%2,397,604250,3612023-12-31
JPMorgan Chase & Co2.462%-17.858%2,058,399-447,4972023-12-31
ARCH VENTURE CORP2.402%0.000%2,008,80902023-12-31
Novo A/S2.392%0.000%2,000,0002,000,0002023-12-31
Baker Bros Advisors LP2.023%19.414%1,691,530275,0002023-12-31
EcoR1 Capital, LLC1.495%0.000%1,250,0001,250,0002023-12-31
Geode Capital Management, LLC1.352%7.340%1,130,16377,2832023-12-31
Goldman Sachs Group Inc1.133%360.857%947,232741,6952023-12-31
MPM Oncology Impact Management LP0.763%-25.617%638,163-219,7772023-12-31
Palo Alto Investors, LLC0.689%0.000%575,817575,8172023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Alphabet Inc14.768%17.063%12,349,0861,800,0002023-12-31
ARK Investment Management LLC8.401%35.084%7,025,1161,824,5492023-12-31
Vanguard Group Inc6.544%13.221%5,471,930638,9622023-12-31
BlackRock Inc5.304%10.931%4,435,481437,0822023-12-31
Federated Hermes Inc4.760%57.180%3,980,3721,448,0032023-12-31
State Street Corporation4.624%17.991%3,866,764589,5842023-12-31
FMR Inc4.119%-47.632%3,444,570-3,132,9922023-12-31
T. Rowe Price Investment Management,Inc.3.796%50.779%3,174,3521,069,0542023-12-31
Casdin Capital, LLC3.599%1.841%3,009,09454,3842023-12-31
Nikko Asset Management Americas Inc2.867%11.660%2,397,604250,3612023-12-31
Sumitomo Mitsui Trust Holdings Inc2.867%11.660%2,397,604250,3612023-12-31
JPMorgan Chase & Co2.462%-17.858%2,058,399-447,4972023-12-31
ARCH VENTURE CORP2.402%0.000%2,008,80902023-12-31
Novo A/S2.392%0.000%2,000,0002,000,0002023-12-31
Baker Bros Advisors LP2.023%19.414%1,691,530275,0002023-12-31
EcoR1 Capital, LLC1.495%0.000%1,250,0001,250,0002023-12-31
Partner Fund Management LP1.897%38.290%1,168,808323,6222022-09-30
Geode Capital Management, LLC1.352%7.340%1,130,16377,2832023-12-31
Goldman Sachs Group Inc1.133%360.857%947,232741,6952023-12-31
Avidity Partners Management LP1.379%-35.000%878,600-473,1002023-06-30
Redmile Group, LLC0.968%-23.747%809,777-252,1832023-09-30
Wellington Management Company LLP0.985%-18.809%792,526-183,6022023-09-30
Deep Track Capital, LP1.258%0.000%775,000775,0002022-09-30
Deerfield Management Co1.218%0.000%750,000750,0002022-09-30
Citadel Advisors Llc1.092%63.827%696,040271,1782023-06-30
Bvf Inc0.777%0.000%650,00002023-09-30
MPM Oncology Impact Management LP0.763%-25.617%638,163-219,7772023-12-31
Cormorant Asset Management, LLC0.993%-14.373%600,000-100,7102022-09-30
Palo Alto Investors, LLC0.689%0.000%575,817575,8172023-12-31
Adage Capital Partners Gp LLC0.893%51.160%540,000182,7632022-09-30
Woodline Partners LP0.648%32.158%521,260126,8392023-09-30
Rock Springs Capital Management LP0.834%0.000%504,03702022-06-30

Mutual Fund Ownership

ARK Genomic Revolution is the biggest individual fund holder of Verve Therapeutics Inc (VERV), owning a total of 3.4 million shares. Combined, the top 30 mutual fund holders of VERV own 52.19% of the company with a total of 42.1 million shares.

In the latest ownership report on February 29th 2024, the top 30 fund holders increased their combined ownership of VERV by 89 thousand shares. 4 funds bought 97,129 total additional shares and increased their ownership by an average of 1.26%. However 2 funds sold 7,792 total shares and decreased their ownership by an average of 0.13%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Verve Therapeutics increased by a net total of 89,337 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Innovation ETF3.632%-0.249%3,036,742-7,5842024-02-29
ARK Genomic Revolution ETF3.564%0.508%2,979,76715,0602024-02-29
SPDR® S&P Biotech ETF3.428%1.905%2,866,45353,5802024-02-29
Vanguard Total Stock Mkt Idx Inv2.208%0.000%1,846,28102024-02-29
Vanguard Small Cap Index1.816%0.955%1,518,75614,3592024-02-29
iShares Russell 2000 ETF1.522%-0.016%1,273,048-2082024-02-29
Vanguard Small Cap Growth Index Inv1.019%1.686%852,23714,1302024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution4.068%19.663%3,401,609558,9502023-12-31
ARK Disruptive Innovation Full Composite3.958%56.149%3,309,2071,189,9472023-12-31
ARK Innovation ETF3.632%-0.249%3,036,742-7,5842024-02-29
ARK Genomic Revolution ETF3.564%0.508%2,979,76715,0602024-02-29
SPDR® S&P Biotech ETF3.428%1.905%2,866,45353,5802024-02-29
Federated Hermes Kaufmann R3.060%91.032%2,558,6851,219,2862023-12-31
Federated Hermes Kaufmann Growth3.060%91.032%2,558,6851,219,2862023-12-31
Vanguard Total Stock Mkt Idx Inv2.208%0.000%1,846,28102024-02-29
Vanguard Small Cap Index1.816%0.955%1,518,75614,3592024-02-29
Federated Hermes Kaufmann Small Cap Grow1.622%17.014%1,356,192197,1922023-12-31
Federated Hermes Kaufmann Small Cap A1.622%17.014%1,356,192197,1922023-12-31
iShares Russell 2000 ETF1.522%-0.016%1,273,048-2082024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr1.955%2.974%1,246,54136,0002023-03-31
Nikko AM ARK Disruptive Innovation A USD1.417%-0.515%1,185,187-6,1362024-01-31
FIAM Small Cap Core CIT Cl B1.362%1.089%1,095,42411,8002023-10-31
FIAM Small Cap Core Composite1.296%145.887%1,083,624642,9242023-09-30
Vanguard Small Cap Growth Index Inv1.019%1.686%852,23714,1302024-02-29
T. Rowe Price Small-Cap Value0.951%55.076%795,431282,5022023-12-31
T. Rowe Price US Small-Cap Core Equity0.936%49.182%782,430257,9502023-12-31
T. Rowe Price Small-Cap Stock0.936%49.182%782,430257,9502023-12-31
Nikko AM ARK Pstv Chg Innovt P JPY Acc0.898%0.000%750,82602024-01-31
Vanguard Institutional Extnd Mkt Idx Tr0.869%-0.698%726,682-5,1042024-01-31
JPMorgan Small Cap Growth A0.869%-2.840%726,206-21,2302024-01-31
Fidelity Advisor® Biotechnology I0.821%20.975%660,394114,5002023-11-30
Vanguard Extended Market Index Investor0.900%-0.023%573,236-1332023-08-31
Fidelity Growth Compy Commingled Pl 30.878%0.000%559,73202023-07-31
Fidelity Growth Compy Commingled Pl O0.878%0.000%559,73202023-07-31
Fidelity® Contrafund®0.906%913.363%558,130503,0532022-10-31
Fidelity® Series Small Cap Opps0.862%0.000%549,37002023-09-30
Fidelity® Small Cap Growth0.881%0.000%544,52202022-12-31

Discussions

Please log in or register to share your thoughts.

unknownable

$VERV one of the poorest performed stocks for a big name.

0 Like Report
kairaae

$VERV when's the offering?

0 Like Report